Source: Pharmacy Times articles
V114, a 15-valent pneumococcal conjugate vaccine (PCV), provided better protection against serotypes 22F and 33F compared with 13-valent PCV (PCV13).
Read More
by MM360 Staff | May 29, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
V114, a 15-valent pneumococcal conjugate vaccine (PCV), provided better protection against serotypes 22F and 33F compared with 13-valent PCV (PCV13).
Read More